MU

See the following -

Beauregard Memorial Hospital running Medsphere's OpenVistA EHR system receives Stage 1 'Meaningful Use' reimbursement

Press Release | Medsphere Systems Corporation | June 12, 2012

Medsphere Systems Corporation and Beauregard Memorial Hospital today announced that Beauregard has received federal reimbursement for the licensing of Medsphere’s OpenVista® electronic health record (EHR). The payment of Stage One Meaningful Use funds to the DeRidder, Louisiana, hospital covers five-year total licensing costs for the OpenVista EHR. The affordability of OpenVista will enable Beauregard to use additional federal funds received for subsequent stages of the Meaningful Use program on other hospital initiatives.

Read More »

FDA Issues Proposed Rule for Unique Device Identifiers

Ken Terry | FierceHealthIT | July 5, 2012

Five years after a request from Congress, the Food and Drug Administration (FDA) has finally issued a proposed rule that would mandate the placement of unique device identifiers (UDI) on medical devices. Among other things, the use of UDIs will facilitate the reporting of adverse events related to these devices so that the FDA can more quickly address them and recall devices if necessary. Read More »

Health IT Orthodoxy after the Supreme Court

John Loonsk | Government Health IT | July 2, 2012

The focus of ACA attention will turn to results or repeal. And while a different decision could have had ACA become a weight on HITECH and health information technology (HIT), the principally bi-partisan nature of the HIT agenda should now refocus attention almost exclusively on results for it. Read More »

Surveys point to struggles in adoption of EHRs

Jeff Rowe | Government Health IT | June 25, 2012

Surveys are intended in part to give researchers a snapshot understanding of what is going on in a given part of society, or any single topic. Sometimes, though, it seems more productive to consider more than one survey at once in the name of getting at potentially broader implications.

Read More »